Anhui Fengyuan Pharmaceutical Co Ltd (000153) — Cash Flow Quality Index
Anhui Fengyuan Pharmaceutical Co Ltd (000153) has a Cash Flow Quality Index of 2.88x as of September 2025. Operating cash flow of CN¥69.15 Million exceeds net income of CN¥24.01 Million, indicating high earnings quality where cash backs reported profits. Explore debt repayment capacity of Anhui Fengyuan Pharmaceutical Co Ltd to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Anhui Fengyuan Pharmaceutical Co Ltd Cash Flow Quality Index (1999–2025)
Historical Cash Flow Quality Index for Anhui Fengyuan Pharmaceutical Co Ltd across 27 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 000153 cash flow metrics.
Annual Cash Flow Quality Index for Anhui Fengyuan Pharmaceutical Co Ltd (1999–2025)
Year-by-year earnings quality comparison for Anhui Fengyuan Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.20x | CN¥119.30 Million | CN¥99.42 Million | ▲ +49.9% |
| 2024 | 0.80x | CN¥126.24 Million | CN¥157.65 Million | ▼ -50.6% |
| 2023 | 1.62x | CN¥254.75 Million | CN¥157.30 Million | ▼ -44.4% |
| 2022 | 2.91x | CN¥439.99 Million | CN¥150.94 Million | ▲ +34.1% |
| 2021 | 2.17x | CN¥237.88 Million | CN¥109.47 Million | ▼ -24.2% |
| 2020 | 2.87x | CN¥292.75 Million | CN¥102.10 Million | ▲ +249.1% |
| 2019 | 0.82x | CN¥66.21 Million | CN¥80.61 Million | ▼ -78.7% |
| 2018 | 3.85x | CN¥233.59 Million | CN¥60.71 Million | ▲ +379.9% |
| 2017 | 0.80x | CN¥52.40 Million | CN¥65.35 Million | ▼ -53.1% |
| 2016 | 1.71x | CN¥78.21 Million | CN¥45.71 Million | ▲ +18.3% |
| 2015 | 1.45x | CN¥45.50 Million | CN¥31.47 Million | ▲ +465.6% |
| 2014 | 0.26x | CN¥10.51 Million | CN¥41.12 Million | ▲ +109.9% |
| 2013 | -2.59x | CN¥-70.31 Million | CN¥27.19 Million | ▼ -202.5% |
| 2012 | 2.52x | CN¥45.65 Million | CN¥18.09 Million | ▼ -54.5% |
| 2011 | 5.55x | CN¥55.06 Million | CN¥9.92 Million | ▲ +308.1% |
| 2010 | 1.36x | CN¥55.04 Million | CN¥40.48 Million | ▼ -0.5% |
| 2009 | 1.37x | CN¥32.41 Million | CN¥23.71 Million | ▼ -58.3% |
| 2008 | 3.28x | CN¥49.82 Million | CN¥15.20 Million | ▼ -65.1% |
| 2007 | 9.38x | CN¥55.26 Million | CN¥5.89 Million | ▲ +473.0% |
| 2006 | 1.64x | CN¥36.27 Million | CN¥22.15 Million | ▼ -56.4% |
| 2005 | 3.76x | CN¥34.88 Million | CN¥9.28 Million | ▲ +422.3% |
| 2004 | -1.17x | CN¥-11.72 Million | CN¥10.04 Million | ▼ -84.5% |
| 2003 | -0.63x | CN¥-11.46 Million | CN¥18.12 Million | ▼ -255.9% |
| 2002 | 0.41x | CN¥10.48 Million | CN¥25.82 Million | ▼ -57.4% |
| 2001 | 0.95x | CN¥23.57 Million | CN¥24.77 Million | ▼ -3.4% |
| 2000 | 0.99x | CN¥25.88 Million | CN¥26.27 Million | ▲ +739.6% |
| 1999 | 0.12x | CN¥1.01 Million | CN¥8.64 Million | — |